Loading data
TLPHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | — | — | — | 2.59 m USD | 3.75 m USD |
| Research and development expense | 6.03 m USD | 6.72 m USD | 5.55 m USD | 3.34 m USD | 4.1 m USD |
| Selling, general and administrative expense | 7.48 m USD | 8.53 m USD | 11.99 m USD | 17.01 m USD | 30.94 m USD |
| Operating profit | -13.48 m USD | -15.25 m USD | -16.89 m USD | -25.3 m USD | -35.97 m USD |
| Interest expense | — | — | 134 k USD | 1.12 m USD | 2.29 m USD |
| Profit before tax | — | — | -10.29 m USD | 59.14 m USD | -35.09 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 13 k USD | 5 k USD |
| Net income (reported basis) | -14.29 m USD | -13 m USD | -18.4 m USD | 47.76 m USD | -35.1 m USD |
| Net income attributable to common shareholders | — | — | -18.4 m USD | 42.33 m USD | -35.1 m USD |
| Basic earnings per share | -0.34 USD/share | -0.5 USD/share | -1.29 USD/share | 5.73 USD/share | -5.86 USD/share |
| Diluted earnings per share | — | — | -1.29 USD/share | 5.72 USD/share | -5.86 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.